Abstract

Mechanisms controlling ureter lenght and the position of the kidney are poorly understood. Glial cell-line derived neurotrophic factor (GDNF) induced RET signaling is critical for ureteric bud outgrowth, but the function of endogenous GDNF in further renal differentiation and urogenital system development remains discursive. Here we analyzed mice where 3′ untranslated region (UTR) of GDNF is replaced with sequence less responsive to microRNA-mediated regulation, leading to increased GDNF expression specifically in cells naturally transcribing Gdnf. We demonstrate that increased Gdnf leads to short ureters in kidneys located in an abnormally caudal position thus resembling human pelvic kidneys. High GDNF levels expand collecting ductal progenitors at the expense of ureteric trunk elongation and result in expanded tip and short trunk phenotype due to changes in cell cycle length and progenitor motility. MEK-inhibition rescues these defects suggesting that MAPK-activity mediates GDNF’s effects on progenitors. Moreover, Gdnf   hyper mice are infertile likely due to effects of excess GDNF on distal ureter remodeling. Our findings suggest that dysregulation of GDNF levels, for example via alterations in 3′UTR, may account for a subset of congenital anomalies of the kidney and urinary tract (CAKUT) and/or congenital infertility cases in humans and pave way to future studies.

Details

Title
Development of the urogenital system is regulated via the 3′UTR of GDNF
Author
Li, Hao 1 ; Jakobson Madis 2 ; Ola Roxana 3 ; Gui Yujuan 1 ; Kumar Anmol 1 ; Sipilä Petra 4 ; Sariola Hannu 2 ; Kuure Satu 5   VIAFID ORCID Logo  ; Jaan-Olle, Andressoo 6   VIAFID ORCID Logo 

 Helsinki Institute of Life Sciences and Faculty of Medicine, Institute of Biotechnology, Helsinki, Finland (GRID:grid.7737.4) (ISNI:0000 0004 0410 2071) 
 University of Helsinki, Institute of Biomedicine, Biochemistry and Developmental Biology, Helsinki, Finland (GRID:grid.7737.4) (ISNI:0000 0004 0410 2071) 
 University of Helsinki, Institute of Biomedicine, Biochemistry and Developmental Biology, Helsinki, Finland (GRID:grid.7737.4) (ISNI:0000 0004 0410 2071); University of Transylvania, Brasov, Romania and Functional Genomics, Proteomics and Experimental Pathology Department, Prof. Dr. I. Chiricuta Oncology Institute, Department of Basic, Preventive and Clinical Science, Faculty of Medicine, Cluj-Napoca, Romania (GRID:grid.5120.6) (ISNI:0000 0001 2159 8361) 
 Research Centre for Integrative Physiology and Pharmacology, and Turku Center for Disease Modeling (TCDM), Institute of Biomedicine, University of Turku, Turku, Finland (GRID:grid.1374.1) (ISNI:0000 0001 2097 1371) 
 Helsinki Institute of Life Sciences and Faculty of Medicine, Institute of Biotechnology, Helsinki, Finland (GRID:grid.7737.4) (ISNI:0000 0004 0410 2071); University of Helsinki, GM-Unit, Laboratory Animal Centre, Helsinki, Finland (GRID:grid.7737.4) (ISNI:0000 0004 0410 2071) 
 Helsinki Institute of Life Sciences and Faculty of Medicine, Institute of Biotechnology, Helsinki, Finland (GRID:grid.7737.4) (ISNI:0000 0004 0410 2071); Care Sciences and Society, Karolinska Institutet, Department of Neurobiology, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626) 
Publication year
2019
Publication date
Dec 2019
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2199192893
Copyright
This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.